Pages that link to "Q45644537"

The following pages link to Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. (Q45644537):

Displaying 18 items.

• HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission (Q28473637) (← links)
• High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression (Q34490116) (← links)
• In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth (Q34937404) (← links)
• Identifying the early post-HIV antibody seroconversion period (Q35129399) (← links)
• HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe (Q35589760) (← links)
• Characterization of acute HIV-1 infection in high-risk Nigerian populations (Q35842274) (← links)
• Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort (Q36280900) (← links)
• Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration (Q36423910) (← links)
• HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. (Q36874604) (← links)
• Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. (Q37240053) (← links)
• In-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries (Q37266495) (← links)
• Use of predictive markers of HIV disease progression in vaccine trials (Q37387810) (← links)
• Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. (Q38088726) (← links)
• Measuring the public-health impact of candidate HIV vaccines as part of the licensing process (Q40121515) (← links)
• Advances in the diagnosis and treatment of acute human immunodeficiency virus type 1 (HIV-1) infection (Q40519226) (← links)
• Primary HIV. (Q43171945) (← links)
• Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine (Q45517703) (← links)
• Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment (Q81433335) (← links)